Mallinckrodt Articles
Actavis settles with Mallinckrodt over Exalgo 32mg; Teva gains FDA OK for Adderall XR
14 February 2013
Covidien files Form 10 registration statement for planned spin-off of Pharma business
4 February 2013
Nuvo Research in patent settlement over Pennsaid
29 January 2013
Mallinckrodt to acquire CNS Thera for $100 million; Mediq to sell out for 775 million euros
25 September 2012
Watson settles over Exalgo; gets favorable news on enoxaparin
29 January 2012
Mallinckrodt Baker/Rubicon in excipient deal
1 September 2008
Ranbaxy revises target on US sales
14 July 2003
Showing 1-10 of 10 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
